Raymond Mak MD, is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women's Hospital/Dana-Farber Cancer Institute. He is a faculty leader in the Artificial Intelligence in Medicine Program at Brigham and Women's Hospital.
Dr. Mak’s clinical focus includes treatment of thoracic malignancies, stereotactic body radiation therapy and novel image-guided radiation therapy techniques. He led the implementation of MR-guided radiation therapy program at BWH/DFCI in 2019.
His research interests focus on developing imaging biomarkers to predict radiation therapy response, outcomes, and toxicity for lung cancer patients, and clinically applying artificial intelligence techniques to automate radiation therapy planning and improve risk stratification.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none